Magnetic urokinase: targeting of urokinase to fibrin clot. 1988

T Yoshimoto, and K Ohwada, and K Takahashi, and A Matsushima, and Y Saito, and Y Inada
Laboratory of Biological Chemistry, Tokyo Institute of Technology, Japan.

A plasminogen activator of human origin, urokinase, was endowed with magnetic property. The magnetic urokinase was composed of magnetite, polyethylene glycol derivative and urokinase, and dispersed in saline. Its particle size of magnetite was approximately 30-60 nm. It was selectively delivered to fibrin clot by magnetic force in continuously circulating plasma and exerted fibrinolytic activity without degrading fibrinogen.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D010087 Oxides Binary compounds of oxygen containing the anion O(2-). The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides. Oxide
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014568 Urokinase-Type Plasminogen Activator A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES. Plasminogen Activator, Urokinase-Type,U-Plasminogen Activator,Urinary Plasminogen Activator,Urokinase,Abbokinase,Kidney Plasminogen Activator,Renokinase,Single-Chain Urokinase-Type Plasminogen Activator,U-PA,Single Chain Urokinase Type Plasminogen Activator,U Plasminogen Activator,Urokinase Type Plasminogen Activator
D052203 Ferrosoferric Oxide Iron (II,III) oxide (Fe3O4). It is a black ore of IRON that forms opaque crystals and exerts strong magnetism. Ferumoxytol,Feraheme,Ferriferrous Oxide,Magnetite,Oxide, Ferriferrous,Oxide, Ferrosoferric
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

T Yoshimoto, and K Ohwada, and K Takahashi, and A Matsushima, and Y Saito, and Y Inada
February 1990, Thrombosis research,
T Yoshimoto, and K Ohwada, and K Takahashi, and A Matsushima, and Y Saito, and Y Inada
May 1985, Thrombosis research,
T Yoshimoto, and K Ohwada, and K Takahashi, and A Matsushima, and Y Saito, and Y Inada
January 1980, Upsala journal of medical sciences,
T Yoshimoto, and K Ohwada, and K Takahashi, and A Matsushima, and Y Saito, and Y Inada
March 1988, Thrombosis research,
T Yoshimoto, and K Ohwada, and K Takahashi, and A Matsushima, and Y Saito, and Y Inada
September 1971, British journal of haematology,
T Yoshimoto, and K Ohwada, and K Takahashi, and A Matsushima, and Y Saito, and Y Inada
January 2003, Thrombosis and haemostasis,
T Yoshimoto, and K Ohwada, and K Takahashi, and A Matsushima, and Y Saito, and Y Inada
January 1996, Ukrainskii biokhimicheskii zhurnal (1978),
T Yoshimoto, and K Ohwada, and K Takahashi, and A Matsushima, and Y Saito, and Y Inada
January 1968, The Biochemical journal,
T Yoshimoto, and K Ohwada, and K Takahashi, and A Matsushima, and Y Saito, and Y Inada
October 2010, Biophysical journal,
Copied contents to your clipboard!